HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Sys. Review
Lactylation Targeting Shows Preclinical Anti-Fibrotic Potential in Liver Fibrosis
New Research Identifies Potential Targets for Liver Fibrosis Treatment
This narrative review examines lactylation, particularly H3K18La, as a mechanistic driver of liver fibrosis and evaluates preclinical interv…
Scientists have identified specific biological pathways and natural compounds that may help slow down the progression of liver fibrosis in e…
Frontiers
Sep 29, 2026
Drug Pipeline
Meta-analysis
Meta-analysis shows salidroside improves metabolic markers in rodent NAFLD models
New Natural Compound Could Lower Liver Fat in Early Tests
This meta-analysis synthesizes data from 12 eligible animal studies investigating salidroside in rodent NAFLD models.
A review of animal studies suggests a specific compound may help heal fatty livers.
Frontiers
Apr 24, 2026
Drug Pipeline
Meta-analysis
Meta-analysis of salidroside in diabetic nephropathy animal models shows mixed renal outcomes with high heterogeneity
Salidroside May Help Protect Kidneys in Diabetes
This systematic review and meta-analysis evaluated salidroside monotherapy in 257 diabetic nephropathy animal models.
A natural compound from Rhodiola may protect kidneys in diabetes by calming inflammation and fighting oxidative stress.
Frontiers
Apr 18, 2026